Skip to content

Clinical trials

Nervous System Diseases trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Nervous System Diseases Country / region: Finland Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20131
20161
20173
20183
20191
20232
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting2
Terminated2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Herantis Pharma Plc.2
Neuroscience Trials Australia2
AbbVie1
Eli Lilly and Company1
Hoffmann-La Roche1
Medtronic1
Novartis Pharmaceuticals1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Renishaw1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Nervous System Diseases14
Brain Diseases10
Central Nervous System Diseases8
Alzheimer Disease6
Dementia6
Neurodegenerative Diseases5
Mental Disorders4
Cardiovascular Diseases3
Cognitive Dysfunction3
Movement Disorders3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.